OVERCOMING ENZALUTAMIDE-RESISTANT WITH A NOVEL ANTI-AR PEPTIDE IN PROSTATE CANCER CELLS

被引：0
|
作者：
Zainfeld, Daniel
Chen, Ruibao
Thrasher, J. Brantley
Li, Benyi
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP84-14
引用
收藏
页码：E1095 / E1095
页数：1
相关论文
共 50 条
  • [41] COMBINED AKT AND MEK PATHWAY BLOCKADE IN PRECLINICAL MODELS OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER
    Toren, Paul
    Kim, Soojin
    Zoubeidi, Amina
    JOURNAL OF UROLOGY, 2016, 195 (04): : E813 - E814
  • [42] Is the Patient Actually Failing on Enzalutamide? A Case Report and Issues to Consider in Enzalutamide-Resistant Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer
    Papageorgiou, Georgios Ioannis
    Skouteris, Nikolaos
    Kosma, Aikaterini
    Markouizou, Athina
    Charalampakis, Nikolaos
    REVIEWS ON RECENT CLINICAL TRIALS, 2023, 18 (02) : 146 - 155
  • [43] Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer
    Simpson, Kendall
    Allison, Derek B.
    He, Daheng
    Liu, Jinpeng
    Wang, Chi
    Liu, Xiaoqi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (01):
  • [44] Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer
    Ye, Chen
    Chen, Yuan-Gui
    Qin, Sheng-Fei
    Tang, Shou-Yan
    Li, Song
    Shi, Min-Feng
    Zhou, Tie
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (05) : 643 - 658
  • [45] GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers
    Wang, Jun
    Xu, Wenhao
    Wang, Beihe
    Lin, Guowen
    Wei, Yu
    Abudurexiti, Mierxiati
    Zhu, Wenkai
    Liu, Chang
    Qin, Xiaojian
    Dai, Bo
    Wan, Fangning
    Zhang, Hailiang
    Zhu, Yao
    Ye, Dingwei
    CANCER LETTERS, 2020, 485 : 45 - 55
  • [46] Targeted Delivery of AR-V7 siRNA with Bivalent PSMA Aptamers Effectively Suppresses the Growth of Enzalutamide-Resistant Prostate Cancer
    Xue, Lu
    Yu, Xiaolin
    Zhao, Lijing
    Garrett, Aria
    Wu, Daqing
    Liu, Hong Yan
    MOLECULAR PHARMACEUTICS, 2024, 21 (11) : 5749 - 5760
  • [47] Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer
    Hoshi, Seiji
    Meguro, Satoru
    Imai, Hitomi
    Matsuoka, Yuta
    Yoshida, Yuki
    Onagi, Akihumi
    Tanji, Ryo
    Honda-Takinami, Ruriko
    Matsuoka, Kanako
    Koguchi, Tomoyuki
    Hata, Junya
    Sato, Yuichi
    Akaihata, Hidenori
    Kataoka, Masao
    Ogawa, Soichiro
    Kojima, Yoshiyuki
    CANCER SCIENCE, 2021, 112 (05) : 1899 - 1910
  • [48] Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
    Han, Yangyang
    Huang, Weiwei
    Liu, Jiakuan
    Liu, Dandan
    Cui, Yangyan
    Huang, Ruimin
    Yan, Jun
    Lei, Ming
    THERANOSTICS, 2017, 7 (07): : 1914 - 1927
  • [49] Aberrant tumor metabolism to enable glucocorticoid receptor takeover in enzalutamide-resistant prostate cancer.
    Sharifi, Nima
    Li, Jianneng
    Alyamani, Mohammad
    Zhang, Ao
    Chang, Kai-Hsiung
    Berk, Mike
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [50] Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes
    Feng, Tao
    Wei, Dechao
    Zhao, Jiahui
    Li, Qiankun
    Guo, Pengju
    Yang, Xiaobing
    Li, Mingchuan
    Jiang, Yongguang
    Luo, Yong
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (15) : 1776 - 1787
12345